Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The targeted therapies led to an 87% reduction in disease progression or death for newly diagnosed chronic lymphocytic leukemia patients.
September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
The FDA is investigating the risk of new T-cell malignancies among patients receiving the engineered T cells, but so far, cases are rare.
CAR-T expert Terry Fry of the University of Colorado Cancer Center talks about new data and future applications for this immunotherapy.
Nearly three quarters of treated patients experienced partial disease regression.
Findings suggest “less is more” and “tried and true” may benefit select patients.
After three bouts with lymphoma, Art Chandler now faced lung cancer. Here’s why he pursued proton therapy, a type of radiation treatment.
Shivani Srivastava receives NCI MERIT Award to investigate how to improve engineered cancer immunotherapies against solid tumors.
EBV causes chromosome breakage that can trigger a cascade of genomic instability leading to tumor growth.
Proposal aligns with President Biden’s Cancer Moonshot by reducing toxic exposures known to cause cancer.
Rosenberg pioneered cancer treatments including tumor-infiltrating lymphocytes and CAR-T therapy.
Novel treatment relies on a newer form of CRISPR gene-editing technology called base editing.
The Leukemia & Lymphoma Society’s Dare to Dream project helps pediatric cancer patients like Cayden, who received CAR-T therapy.
Some people with lymphoma and treated with a type of chemo drug called anthracyclines may benefit from a cholesterol drug, research shows.
“I envision LLS continuing to be a leading innovator, driving change that impacts all cancer care,” says E. Anders Kolb, MD.
For the research team, the question was: “Can we turn something that is good for the cancer into something that will kill [it]?”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.